Elevance Health (ELV) Short-term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Short-term Investments data on file, last reported at $25.9 billion in Q1 2026.

• Short-term Investments for Q1 2026 came in at $25.9 billion, up 3523.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 billion (up 3523.08% YoY), and the FY2025 annual result was $740.0 million, down 97.06% from the prior year.
• Short-term Investments grew to $25.9 billion in Q1 2026 per ELV's latest filing, from $740.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $29.6 billion in Q4 2023 and troughed at $165.0 million in Q3 2023.
• A 5-year average of $11.3 billion and a median of $1.5 billion in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments slumped 98.94% in 2023, then jumped 4158.92% in 2025.
• A 5-year view of Short-term Investments shows it stood at $26.0 billion in 2022, then increased by 14.11% to $29.6 billion in 2023, then dropped by 14.9% to $25.2 billion in 2024, then sank by 97.06% to $740.0 million in 2025, then surged by 3400.68% to $25.9 billion in 2026.
• Business Quant data shows ELV's Short-term Investments at $25.9 billion in Q1 2026, $740.0 million in Q4 2025, and $26.3 billion in Q3 2025.